















working to change the course of blood cancers | geron
































 









your browser's javascript is disabled.
to properly view the content on this page, please enable javascript.






































research & development

pipeline
telomerase inhibition
clinical trials


patients
medicines
investors & media

press releases
events
stock information
corporate governance
sec filings
analyst coverage
faqs


about

leadership
culture
history
contact
partnering


careers
 


























our ambition is to change lives by changing the course of blood cancer.
powered by pioneering science






learn more

















medicines













our medicine approved for use in the united states ›






investor event













geron to announce fourth quarter and full-year 2024 financial results and business highlights on february 26 >

















research & development
developing innovative medicines for myeloid hematologic malignancies
learn how we’re building on nobel prize-winning science
explore our r&d 
















patients













we are on a mission to extend and enhance patients’ lives ›






culture













we see things in ways others do not ›















careers

join us and become a part of something special










search for opportunities

















explore
research & development
pipeline
partnering
patients
 

browse
publications
corporate profile
press releases
events
 



learn
about
leadership
culture
history
 

connect
careers
locations
contacts
 

follow













terms of use
privacy policy
cookie policy
state regulations




copyright © 2025 geron. all rights reserved














geron (the “company”) recognizes the value of each individual and is committed to providing equal employment and advancement opportunities. in accordance with applicable law, we prohibit discrimination against any applicant or employee based on any applicable legally-protected basis, including, but not limited to: an individual’s age (40 years and over or as protected by relevant law), race (including but not limited to, hair texture, hair type, and protective hairstyles such as braids, locks, and twists), color, national origin, nationality, ancestry, citizenship, creed, religion (including religious dress and grooming practices), sex, sexual orientation, gender (including transgender status, gender identity, and gender expression), reproductive health decision-making, pregnancy (including childbirth, lactation, and related medical conditions), marital status, civil union status, domestic partnership status, atypical hereditary cellular or blood trait, american flag display, political affiliation, physical or mental disability, medical condition, genetic information (including testing and characteristics), veteran status, uniformed servicemember status, protected leave status, domestic violence victim status, or any other status protected by applicable federal, state, or local laws.
the policy of equal employment opportunity encompasses all aspects of the employment relationship including hiring, promotion, transfer, selection for training opportunities, wage and salary administration, and the application of benefit plans and company policies.



 













